Updates are available Correction dated 2024-04-22
Click to view Correction: https://doi.org/10.1038/s41589-024-01623-3
-
Authors
Li, Min
Wang, Zheng
Tao, Jingjing https://orcid.org/0000-0001-6473-3797
Jiang, Hongfei
Yang, Huang
Guo, Dong
Zhao, Hong
He, Xuxiao
Luo, Shudi
Jiang, Xiaoming
Yuan, Li
Xiao, Liwei
He, Haiyan
Yu, Rilei https://orcid.org/0000-0002-9611-3514
Fang, Jing
Liang, Tingbo https://orcid.org/0000-0003-0143-3353
Mao, Zhengwei https://orcid.org/0000-0001-7990-2856
Xu, Daqian https://orcid.org/0000-0003-0478-2997
Lu, Zhimin https://orcid.org/0000-0002-2859-2736
- License Information
-
More Information
Article History
Received: 31 August 2023
Accepted: 1 March 2024
First Online: 27 March 2024
Change Date: 22 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41589-024-01623-3
Competing interests
: Z.L. owns shares in Signalway Life Sciences, which supplied the rabbit antibodies that recognize TERT pS227. Z.L.’s interest in this company had no bearing on its being chosen to supply these reagents. The remaining authors declare no competing interests.
